Weinblatt, M. E., Baranauskaite, A., Dokoupilova, E., Zielinska, A., Jaworski, J., Racewicz, A., . . . Ghil, J. (2018). Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty‐Two–Week Phase III Randomized Study Results. Arthritis Rheumatol.
শিকাগো স্টাইলে সাইটেশনWeinblatt, Michael E., et al. "Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty‐Two–Week Phase III Randomized Study Results." Arthritis Rheumatol 2018.
এমএলএ সাইটেশনWeinblatt, Michael E., et al. "Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty‐Two–Week Phase III Randomized Study Results." Arthritis Rheumatol 2018.